OICR established the Cancer Therapeutics Innovation Pipeline (CTIP) to help move Ontario-developed potential therapies through development and into clinical use by stimulating collaboration within the field of cancer therapeutics discovery. By providing funding and guidance to promising projects in both the early and later stages of development, CTIP is helping to maximize the impact of Ontario’s cancer drug discovery research and ensure that the province remains a world leader in the field.